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Abstract
Vitamin K is essential for the synthesis of proteins belonging to the Gla-protein family. To the members of
this family belong four blood coagulation factors, which all are exclusively formed in the liver. The
importance of vitamin K for hemostasis is demonstrated from the fact that vitamin K-deficiency is an acute,
life-threatening condition due to excessive bleeding. Other members of the Gla-protein family are osteocalcin,
matrix Gla-protein (MGP), and Gas6 that play key functions in maintaining bone strength, arterial
calcification inhibition, and cell growth regulation, respectively. In total 17 Gla-proteins have been discovered
at this time. Recently, it was observed that the dietary vitamin K requirement for the synthesis of the
coagulation factors is much lower than for that of the extra-hepatic Gla-proteins. This forms the basis of
the triage theory stating that during poor dietary supply, vitamins are preferentially utilized for functions that
are important for immediate survival. This explains why in the healthy population all clotting factors
are synthesized in their active form, whereas the synthesis of other Gla-proteins is sub-optimal in non-
supplemented subjects. Prolonged sub-clinical vitamin K deficiency is a risk factor for osteoporosis,
atherosclerosis, and cancer. Present recommendations for dietary intake are based on the daily dose required
to prevent bleeding. Accumulating scientific data suggests that new, higher recommendations for vitamin K
intake should be formulated.
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V
itamin K received its name from the fact that it
is required for normal blood coagulation, and
during about half a century it was believed that
hemostasis was the only metabolic process in which
vitamin K is involved. This view is obsolete now. Since
the identification of Gla as the result of vitamin K action,
it became possible to search for vitamin K-dependent
proteins on the basis of their amino acid structure: each
protein in which gammacarboxyglutamate, generally
referred to as Gla, is found contains the fingerprint of
vitamin K action during its biosynthesis (1). In this way a
wide variety of proteins were found ranging from
osteocalcin (the most abundant non-collagenous protein
in bone), to matrix Gla-protein (MGP, the potent
calcification inhibitor in our arteries), and the growth-
arrest sequence-6 protein (Gas6, a protein involved in cell
growth regulation). Whereas the proteins involved in
blood coagulation invariably are synthesized in the liver,
the newly discovered Gla-proteins have key functions
in other metabolic processes and are synthesized in a
wide variety of tissues. An overview of the various Gla-
proteins and their functions (as far as they are known) is
given in Table 1.
ThemolecularfunctionofvitaminKispreciselyknown:
it serves as a cofactor for the enzyme gammaglutamate
carboxylase (GGCX), which is found in the endoplasmic
reticulum of a wide variety of mammalian cells and that
catalyzes the conversion of the amino acid glutamate into
Gla. The oxidation of vitamin K hydroquinone provides
the energy required for this carboxylation reaction. All
Gla-proteins are secretory proteins found in the extra-
cellular matrix or in body fluids. Gla-residues form strong
calcium-binding groups in the proteins to which they are
attached and in all cases in which their function is known
the Gla-residues are essential for the function of these
proteins (2).
All Gla-proteins known today contain multiple Gla-
residues per molecule ranging from three in the bone
Gla-protein osteocalcin to 10in prothrombin andas much
as 16 in Gla-rich protein (GRP). The position of the Gla-
residues within the respective proteins is well-defined, but
in the case of vitamin K insufficiency under-carboxylated
or even uncarboxylated Gla-proteins are synthesized.
Such proteins lack biological activity and may be regarded
as biomarkers for vitamin K insufficiency. The most
accurate definition of vitamin K is therefore: a compound
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protein-bound glutamate by serving as a coenzyme for the
GGCX enzyme.
Vitamin K in our diet
Vitamin K is not a single compound, butagroup name for
a family of related structures that all share a methylated
naphthoquinone ring system substituted with a variable
aliphatic side chain (3). In phylloquinone (vitamin K1) the
side chain is composed offour isoprenoidresidues, the last
three of which are saturated. Menaquinones (vitamin K2)
form a sub-family in which the length of the side chain
may range from 1 to 13 isoprene residues, all of which
are unsaturated. The various menaquinones are generally
denoted as MK-n, where n represents the number of
isoprene residues in the aliphatic side chain. Important
menaquinones are the short chain MK-4 and the long
chain menaquinones MK-7, MK-8, MK-9, and MK-10
that alloccur in the humandiet, whereas small amountsof
MK-6 have also been found in various foods.
Vitamin K1 is formed in plants and important sources
in our diet are green leafy vegetables such as spinach,
broccoli, Brussels sprouts, and kale. It is located in the
chloroplasts where it forms part of the electron transport
system and about 90% of the total vitamin K in the
western diet is formed by K1. Menaquinones (except
MK-4) are of microbial origin and relatively high
concentrations are only found in a few food items. Natto
is a traditional Japanese food consisting of fermented
soybeans; Bacillus subtilis natto is the source of vitamin
K2 (almost exclusively MK-7) in this food, which may
contain up to 1100 mgo fK 2 per 100 grams of food. The
sharp taste of natto is highly appreciated in Japan but not
in western societies. Other vitamin K2-producing bacteria
are lactic acid bacteria (mainly MK-8 and MK-9) and
propionic acid bacteria (mainly MK-10). Both strains are
used in the production of cheese and curd cheese, which
form the richest sources of vitamin K2 in Europe and
Northern America. Small amounts of MK-4 may also
be obtained from animal products such as meat and
egg yolk; the MK-4 originates from menadione (2-methyl
naphthoquinone), which is added to the animal food, and
which is converted into MK-4 after uptake in the blood
stream. It has also been reported that flatfish and eel,
living at the bottom of the seas and lakes, contain small
amounts of K2 that were regarded to originate from the
bacteria in decomposing organic material serving as their
food.
Pharmacokinetics and efficacy of different forms of
vitamin K
As can be understood from their molecular structures,
the lipophylicity of the various K-vitamins differs subs-
tantially with increasing fat-solubility at increasing side
chain length. Whereas menadione (no side chain) is
water-soluble, phylloquinone and MK-4 are mildly
hydrophobic, and the long chain menaquinones (MK-7
and higher) areonly soluble in apolarorganic solvents like
hexane.
Intestinal uptake of K-vitamins is substantially affected
by the food matrix in which it is embedded. Vitamin K1,
for instance, is tightly bound to the chloroplasts of green
vegetables from which it is hardly liberated in the digestive
tract. Uptake from cooked spinach and broccoli is 510%
only, which can double by concomitant fat intake. K2-
vitamins, on the other hand, are mainly found in the fat
fraction of dairy and are absorbed almost completely (4).
From these data it can be understood that, although 90%
ofour vitamin K intake consists of K1, phylloquinone and
menaquinones contribute more or less equally to the
humanvitamin K status. Also purified forms of vitamin K
that may be present in food supplements and functional
foods are readily absorbed, especially in combination with
a meal (4).
After intestinal uptake, all K-vitamins are incorporated
in triglyceride-rich lipoproteins and transported to the
liver. A remarkable difference is that most of vitamin K1 is
retainedbythelivertobeusedforclottingfactorsynthesis,
whereas K2-vitamins are incorporated into low density
lipoproteins (LDL) and set free in the blood stream (5).
In this way extrahepatic tissues including bone and
arteries are supplied with the vitamin K required for
extrahepatic Gla-protein carboxylation. The different
transport systems for vitamins K1 and K2 form the basis
for their different target tissues. Since no specific receptors
forvitaminK havebeendiscoveredat theouter membrane
of various cells, it is likely that LDL-bound vitamin K
is taken up by the cells via the LDL-receptors and
subsequently dissolves in the membrane structures of the
cells, notably the endoplasmic reticulum where it displays
its cofactor function.
Another difference between K1 and MK-4 on the one
hand and the long-chain menaquinones on the other
hand is their biological half-life time in the blood stream
(5). Whereas K1 and MK-4 typically exhibit half-life
times of 11.5 hour, long chain menaquinones such as
MK-7 and MK-9 are characterized by half life times of
several days (4, 6). This was demonstrated in a volunteer
experiment in which equal amounts of K1 and MK-7
were ingested; it resulted that K1 had almost completely
disappeared after 8 hours, whereas MK-7 (almost
exclusively bound to LDL) remained detectable until
more than 4 days. Similar observations were made for
MK-9 (LJ Schurgers, unpublished data). It must be
concluded, therefore, that the long-chain menaquinones
remain available longer for take up by extrahepatic tissues
and that more constant circulating levels are generated
because the postprandial fluctuations are smaller than in
the case of K1.
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Frequency
Hepatic vitamin K-insufficiency in healthy adults has
never been reported, and it is generally accepted that
all vitamin K-dependent coagulation factors are fully
carboxylated in the normal adult population. This is
in sharp contrast to the extra-hepatic Gla-proteins.
Conformation-specific antibodies have been developed
for osteocalcin and MGP and it was demonstrated that
in non-supplemented adults between 20 and 30% of
both proteins occurs in the non-carboxylated state (7, 8).
Only after supplementation with1 mg/day of vitamin
K1 or 200 mg/day of MK-7 extrahepatic Gla-protein
carboxylation was near to completeness (8). The conse-
quence of this observation is that, for instance, the arterial
vessel wall produces 30% of the MGP in an inactive form,
which means that protection against vascular calcification
is only 70% of what could be achieved at higher vitamin K
intake (9). A general tendency is that under-carboxylation
even increases at increasing age. In this perspective it is a
reason for concern that the vitamin K consumption in the
western society has decreased during the last centuries,
especially during the last 50 years (10).
Risk factor for cardiovascular morbidity and mortality
After extensive databases had been constructed for the
vitamin K1- and vitamin K2-content of various food
items, population-based studies were initiated to correlate
vitamin K intake with cardiovascular disease. In a first
survey, Geleijnse et al. (11) demonstrated that vitamin K2
intake is inversely correlated with cardiovascular disease
and mortality. Remarkably, no association was found
with the intake of vitamin K1. The study was a 10-year
follow-up of 4,500 elderly subjects (the Rotterdam study
cohort) with a highest quartile for K2 intake of 45 mg/day.
These data were confirmed by Gast et al. (12) in over
16,000 participants of the Prospect study. Because of the
large number of subjects and the long follow-up period,
the effects of individual menaquinones could be tested.
Long-chain menaquinones (MK-7 and higher) turned
out to have the most beneficial effects on cardiovascular
disease, with a mortality risk reduction of 9% for each
10 mg/day of extra intake. These outcomes prompted us to
develop a more direct test for vascular vitamin K status
and obviously circulating MGP was the target biomarker
for such test.
During recent years, monoclonal antibodies specifically
recognizing carboxylated MGP (cMGP) and un-
carboxylated MGP (ucMGP) have been created (VitaK,
Maastricht, the Netherlands). These antibodies were used
to build tests based on the ELISA principle with which
both conformations could be quantified in blood plasma.
The most successful tests thus far have been tests for
total ucMGP (t-ucMGP) and desphospho-ucMGP
(dp-ucMGP),afractionoft-ucMGPwithverylowaffinity
for vascular calcium precipitates. Circulating t-ucMGP
was found to be inversely correlatedwith arterial calcifica-
tion in various patient populations (8). Moreover, dp-
ucMGP wasfound to be directly associatedwith mortality
in several patient populations (aorta stenosis, chronic
kidney disease) (13, 14). In a number of studies, plasma
dp-ucMGP was found to be a strong and independent risk
factor for the development of cardiovascular disease and
mortality. Also, it was found that increased vitamin K2
intake (from supplements) quickly decreased dp-ucMGP
in a dose-dependent way (C. Vermeer, unpublished data).
Whether this also leads to a concomitant cardiovascular
risk reduction is subject of investigation at this time.
Risk factor for fractures
Poor vitamin K status was also found to be associated
with low bone mass, osteoporosis, and fracture risk.
Three different methods were used to assess poor vitamin
K status: low circulating vitamin K1 (15), low vitamin K
intake(16),andelevatedcirculatinglevelsoftheboneGla-
protein osteocalcin (17, 18). All three approaches readily
showed the inverse association between vitamin K
status and fracture risk. Remarkably, throughout the
literature the association between vitamin K status and
fracture incidence seems to be more evident than effects
on bone mineral density (BMD), the golden standard
for osteoporotic fracture risk. Moreover, vitamin K inter-
vention studies have shown contradictory results with
some studies showing a positive effect on bone health (as
measured by BMD) and others with no measurable effect.
Oneexplanationfortheseapparentlycontradictoryresults
is that BMD is not an appropriate endpoint to monitor
effects of vitamin K on bone health. Also, it should be
realized that in epidemiological studies only poor vitamin
Kstatusisassociatedwithincreasedfracturerisk.Itwould
Table 1. Classiﬁcation of the 17 Gla-proteins according to their
function
Function Name of protein
Haemostasis (procoagulant
activity)
Prothrombin, factors VII, IX, and X
Haemostasis (anticoagulant
activity)
Proteins C, S, and Z
Artery calcification inhibition Matrix Gla-Protein (MGP)
Bone metabolism Osteocalcin
Cell growth regulation Growth-arrest sequence 6 protein
(Gas6)
Functions unknown Gla-rich protein (GRP)
Periostin
Periostin-like factor
Four transmembrane Gla-proteins
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supplements on bone health in subjects pre-selected for
poor dietary vitamin K status. Such studies have not yet
been published today, however.
Risk for age-related diseases
Most vitamins have been identified from life-threatening
and acute diseases during periods of deficiencies. For
vitamin K this is bleeding, other examples are vitamin C
(scurvy)andvitaminD(rickets).Herewewillrefertothese
diseases as the primarydeficiency diseases. Recommended
daily allowances or dietary reference intakes have been
defined as the minimal intake required to prevent the
primary deficiency diseases in the majority of the popula-
tion. During recent years it has become increasingly clear,
however, that most vitamins are involved in more
metabolic processes than those underlying primary
deficiency diseases. Prolonged sub-clinical vitamin
insufficiency may not be life-threatening with immediate
effect, but forms a risk factor for the development of
age-related diseases, which will be referred to as secondary
deficiency diseases. Vitamin C is now known for its
antioxidant activity, whereas vitamin D is an important
factor in the prevention of diseases ranging from
neuro-musculatory diseases to cancer. Vitamin K, the
blood coagulation vitamin, is now known to be required
for the prevention of osteoporotic bone loss, vascular
calcification, whereas  via Gas6, a ligand for tyrosine
kinase  it is also involved in the regulation of cell growth.
The fact that several other Gla-containing proteins of as
yet unknown function have been discovered recently
suggests that even more vitamin K-dependent metabolic
processes may come to light in the near future.
The triage theory  as formulated by McCann and
Ames (19)  implies that during evolution, living organ-
isms have developed systems ensuring preferential
transport of vitamins and trace elements to the tissues
important for primary deficiency disease prevention.
Since bleeding to death is the major and acute threat of
vitamin K deficiency, vitamin K entering our blood
stream is preferentially transported to the liver, the place
where the coagulation factors are synthesized. Only
after hepatic vitamin K requirement has been met, the
excess vitamin K is transported to extra-hepatic tissues.
Secondary (or sub-clinical) vitamin K deficiency would
then form an increased risk factor for accelerated bone
loss, vascular calcification, and cancer. Indeed all these
associations have been reported in the literature (8, 17,
20). The accumulation of risk factors for age-related
diseases would be the mechanism underlying the shorter
life-expectancy for subjects experiencing long-lasting
poor vitamin K status that was observed by several
independent groups.
Supplementation
Strategies
The fact that under-carboxylation of key Gla-proteins
is common in the general population suggests that
increased vitamin K intake may be an important factor
in improving public health. The following groups need
our specific attention, however:
1) Children. Osteocalcin is one of the most abundant
proteins in the human body, and during growth its
synthesis is at least 10-fold higher than after peak
bone mass has been reached. This means that the
vitamin K requirement of children is much larger
than that of adults (21). Regrettably, the increasing
consumption of fast food and snacks has resulted
in declining vitamin K consumption by children
year after year. Several studies have demonstrated
that  as decided from the extent of Gla-protein
carboxylation  the vitamin K status of children
during growth is extremely poor. On the basis of the
data presently available, we cannot conclude whether
sub-clinical vitamin K-deficiency during the first
20 years of life will have health implications at later
ages (as predicted by the triage theory), but certainly
this is a point of concern that needs our immediate
attention.
2) Pregnant women. Vitamin K is a fat-soluble vitamin,
which implies that it is not freely transported across
theplacenta.Nevertheless,thegrowingfetusisinneed
ofvitaminKthatisextractedfromthemother’sblood
stream. It has been demonstrated that especially
during the last trimester of pregnancy the vitamin K
statusofthemotherdecreases,andthatsupplemented
vitamin K results in improvement of osteocalcin
carboxylation both in the mothers and the newborn
(cordblood measurement)(22). ThevitaminKstatus
of the newborn is extremely low, which is the reason
why vitamin K-supplementation immediately after
birth is mandatory in most countries worldwide.
Hemorrhagic disease of the newborn (HDN) is a
seriouscomplicationinnon-supplementedbabiesand
during the entire period of breast-feeding. It is
noteworthy that humans are the only mammals in
whichbreastmilkissolowinvitaminKthatthechild
needs supplementation to prevent life-threatening
complications. The fact that breast milk can be
rapidly enriched by increasing the mother’s vitamin
K intake illustrates once more that during the last
centuries changed dietary habits have resulted in a
decline of vitamin K intake to dangerously low levels
(23).
3) Elderly. It has been reported that osteocalcin
carboxylation (as a marker for general vitamin K
Cees Vermeer
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related to less food intake, decreased intestinal
absorption, or increasedrequirement. Unfortunately,
this coincides with the onset of age-related
phenomena like increased rate of bone loss and
vascular calcification. Of course these processes are
multifactorial, but the accumulation of risk factors
generally multiplies the risk. If sub-clinical vitamin
K-deficiency may be regarded as one independent
risk factor, annihilating this single risk factor may
contribute substantially to postponing the disease. A
3-year placebo-controlled randomized clinical trial
for the effect of vitamin K2 (MK-7) supplements in
this age group is therefore in progress in our institute.
4) Patients with impaired intestinal absorption. Crohn’s
disease, cystic fibrosis, and galactosemia are chronic
diseases, all of which have been reported to be
associated with poor vitamin K status (25). Without
doubt subjects suffering from these diseases need
vitaminK-containingsupplements,butthesediseases
are out of the scope of this paper.
Safety
Since the primary deficiency disease associated with
vitamin K is bleeding due to impaired blood clotting,
it is often thought that high intake of vitamin K may
increase thrombosis risk. This is evidently not true. Full
carboxylation (and thus: maximal procoagulant activity)
of the vitamin K-dependent clotting factors is essential,
and vitamin K metabolism has been designed to meet
that goal with highest priority. Excess vitamin K intake
cannot result in more clotting factor carboxylation. This
has also been demonstrated within our institute in
thousands of subjects taking high doses of vitamin K
during several years. Even when monitored with the most
sensitive techniques (endogenous thrombin potential,
ETP), an increased thrombosis tendency was not found
in any of the participants. An exception is formed by
patients receiving oral anticoagulants like warfarin
or acenocoumarol that act as vitamin K-antagonists.
Obviously excess vitamin K intake will interfere with this
medication. On the other hand it is becoming increasingly
clear that the long-term use of these drugs is associated
withacceleratedboneloss,lowbonemass,andwidespread
valvular and arterial calcifications (26), thus demonstrat-
ing once more the importance of vitamin K for bone and
vascular health.
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